3 ms·
That's no inflation adjusted. And it's also not adjusted for processing load. But it does show the greatly increased role of user fees, which I gather has facil
by mirimir 7y ago
That's no inflation adjusted. And it's also not adjusted for processing load. But it does show the greatly increased role of user fees, which I gather has facilitated regulatory capture.
- refurb 7y agoInflation hasn’t been 600% since 1992. Not sure what processing load is, but if they’re asked to do more that could be an issue, but I wouldn’t call it a cut.
- mirimir 7y agoI do remember reading about cuts in FDA resources. As an excuse for why they'd missed so many violations. Checking, I see that it was Reagan era cuts.[0] So the timeline that you cited begins in 1992, which was probably the minimum funding level.[1,2] Also, Hatch-Waxman was approved in 1984, which increased the workload considerably. And then there was the first generic drug scandal in the late 80s. That's what I was thinking of. 0) https://academic.oup.com/shm/article-abstract/29/1/202/2472270?redirectedFrom=fulltext https://academic.oup.com/shm/article-abstract/29/1/202/24722... 1) https://www.everycrsreport.com/reports/R44576.html#_Toc8219812 https://www.everycrsreport.com/reports/R44576.html#_Toc82198... 2) https://sci-hub.tw/https://doi.org/10.1093/shm/hkv106 https://sci-hub.tw/https://doi.org/10.1093/shm/hkv106